Mark McDade, CEO at PDL BIOPHARMA, INC. (PDLI), sold 10,000 shares at $21.46 ($215K) on 2007-01-17, disclosed to the SEC on 2007-01-19.
Scheduled sale ($215k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.45 | 7,700 | $165K | 77.0% |
| 2 | $21.46 | 2,300 | $49K | 23.0% |
| Total | $21.45 avg | 10,000 | $215K | 100% |
| Filing → |
| AIMT | BUY | 2015-08-11 | $267K | — | Filing → |
| PrivatePHILLIPS EDISON GROCERY CENTER REIT II, INC. | BUY | 2015-07-17 | $9K | — | Filing → |
| PrivatePHILLIPS EDISON GROCERY CENTER REIT II, INC. | BUY | 2015-05-08 | $9K | — | Filing → |